Actively Recruiting
Neurocognitive Risks in Children With Solid Tumors
Led by Gustave Roussy, Cancer Campus, Grand Paris · Updated on 2024-12-13
1000
Participants Needed
1
Research Sites
569 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The survival rate of children with cancer has improved significantly in recent years thanks to the progress of different therapies. The neurocognitive sequelae related to treatments and illness are more or less well known. Four factors seem to be associated with neurocognitive sequelae: treatment, the tumor itself, environmental factors like the socio-economic status of parents and biological factors. Main purpose of the study is to establish a score to assess the risk of neurocognitive sequelae in these children based on these factors (treatment, tumor, and environmental factors)
CONDITIONS
Official Title
Neurocognitive Risks in Children With Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient aged 6 to 16 years and 11 months during the study period
- Diagnosis of a solid tumor
- Treatment and follow-up at Gustave Roussy
- Minimum 6 months since end of initial treatment for patients not treated with methotrexate
- No minimum time since treatment for patients treated with methotrexate
- Parental or legal representative non-opposition obtained
- Affiliated to a social security scheme
You will not qualify if you...
- Patients with other pathologies linked to mental retardation such as autism or genetic syndromes
- Patients lost to follow-up
- Deceased patients
- Patients treated for pathologies with very short-term prognosis (e.g., infiltrating brainstem glioma, recurrence during treatment)
- Non-French speaking patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gustave Roussy
Villejuif, Val De Marne, France, 94805
Actively Recruiting
Research Team
C
Christelle DUFOUR, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here